World’s first trial in ocular regenerative medicine
Sunday, August 11 2013 | 00 h 00 min | News
The world's first trial in regenerative medicine will be aimed at treating a form of age-related macular degeneration with induced pluripotent stem...
Read MoreFluoroquinolones associated with retinal detachment
Wednesday, August 7 2013 | 00 h 00 min | News
Health Canada warns against the risks of retinal detachment associated with oral fluoroquinolones Five oral fluoroquinolones are available in...
Read MoreOakley supplies Canadian Olympic team
Monday, August 5 2013 | 00 h 00 min | News
As the result of a licensing agreement with the Canadian Olympic Committee, Oakley Canada will be the official supplier of high-performance eyewear...
Read MoreQuebec product in Bausch + Lomb’s portfolio
Sunday, August 4 2013 | 00 h 00 min | News
Mimetogen, a Montréal pharmaceutical company, has granted Bausch + Lomb an option to license MIM-D3, a treatment for dry-eye syndrome Without...
Read MoreEssilor acquires Transitions Optical
Monday, July 29 2013 | 00 h 00 min | News
Essilor International announced today that it has signed an agreement to acquire the 51% stake in Transitions Optical owned by PPG The French giant...
Read More
